Treatment strategy in fibromyalgia syndrome: where are we now?

P Sarzi-Puttini, D Buskila, M Carrabba, A Doria… - Seminars in arthritis and …, 2008 - Elsevier
INTRODUCTION: The treatment of the fibromyalgia syndrome (FMS) is not standardized and
often ineffective, and the course of disease progression is unpredictable. OBJECTIVES: To …

Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?

…, A Andreoli, M Pecis, S Colombo, M Carrabba… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: In the dynamic organization of sleep, cyclic alternating pattern (CAP) expresses
a condition of instability of the level of vigilance that manifests the brain's fatigue in …

[HTML][HTML] Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

…, S de Portu, G Cecchini, C Cruini, M Carrabba… - Arthritis research & …, 2005 - Springer
Studies on autoantibody production in patients treated with tumor necrosis factor-α (TNF-α)
inhibitors reported contradictory results. We investigated in a prospective study the efficacy of …

Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value

…, A Ghirardello, M Turiel, A Batticciotto, M Carrabba… - …, 2008 - Taylor & Francis
Objectives: The aim of this study was to assess thyroid function as well as the prevalence and
clinical value of anti-thyroid antibodies in patients with rheumatoid arthritis (RA). Methods: …

Potential target of infliximab in autoimmune and inflammatory diseases

F Atzeni, A Doria, M Carrabba, M Turiel… - Autoimmunity …, 2007 - Elsevier
Tumour necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine produced by many cell
types (blood monocytes, macrophages, mast cells and endothelial cells), that play a key role …

[HTML][HTML] Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis

…, F Atzeni, F Minonzio, P Bonara, A Doria, M Carrabba - Arthritis Res Ther, 2005 - Springer
Neutrophils are known to be targets for the biological activity of tumour necrosis factor (TNF)-α
in the pathogenensis of rheumatoid arthritis (RA). Therefore, these cells may be among …

Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up

…, A Ghirardello, D Villalta, S Zampieri, M Carrabba… - …, 2008 - Taylor & Francis
Background: Rheumatoid arthritis (RA) is frequently associated with organ or non-organ-specific
autoantibodies or overt autoimmune disorders. Aim of our study was to assess the …

Anti-polymer antibodies are inversely correlated with pain and fatigue severity in patients with fibromyalgia syndrome

…, D Dell'Acqua, S De Portu, V Riccieri, M Carrabba… - …, 2008 - Taylor & Francis
Objective: To investigate the prevalence of antipolymer antibody (APA) in patients with
fibromyalgia (FM) and to examine its association with FM severity symptoms. Methods: The study …

Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease

…, M Motta, G Cighetti, M Carrabba… - Leukemia & …, 2001 - Taylor & Francis
Hyperhomocysteinemia (HH) has been associated with cardiovascular and autoimmune
diseases and oxidative cell damage. Myelodysplastic syndromes (MDS) are associated with …

Rheumatoid Arthritis and the Skin

P Sarzi-Puttini, F Atzeni, M Carrabba - Handbook of Systemic Autoimmune …, 2006 - Elsevier
Publisher Summary Rheumatoid arthritis (RA) is a chronic inflammatory systemic disorder of
unknown etiology. This disease affects about 0.5–1% of the population worldwide, most …